Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
Queen's University · University of Toronto · +5 more institutions
Abstract
The Canadian Network for Mood and Anxiety Treatments (CANMAT) conducted a revision of the 2009 guidelines by updating the evidence and recommendations. The scope of the 2016 guidelines remains the management of major depressive disorder (MDD) in adults, with a target audience of psychiatrists and other mental health professionals.
Using the question-answer format, we conducted a systematic literature search focusing on systematic reviews and meta-analyses. Evidence was graded using CANMAT-defined criteria for level of evidence. Recommendations for lines of treatment were based on the quality of evidence and clinical expert consensus. “Neurostimulation Treatments” is the fourth of six sections of the 2016 guidelines.
Citation impact
- FWCI
- 23.39
- Percentile
- 100%
- References
- 100
Authors
14Topics & keywords
- Neurostimulation
- Electroconvulsive therapy
- Vagus nerve stimulation
- Anxiety
- Transcranial magnetic stimulation
- Tolerability
- Major depressive disorder
- Mood
- Good health and well-being
Funding
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- FBFondation Brain Canada
- SSunovion
- UHUniversity Health Network
- CICampbell Institute
- VPValeant Pharmaceuticals International
- CNCanadian Network for Mood and Anxiety Treatments
- CFCentre for Addiction and Mental Health Foundation
- BBrainsWay
- QUQueen's University
- GCGrand Challenges Canada
- MDMinistero dello Sviluppo Economico
- VCVancouver Coastal Health Research Institute
- SServier
- HLH. Lundbeck A/S
- NINational Institutes of Health
- SJSt. Jude Medical
- AAllergan
- UHUniversity Health Network Foundation
- CICanadian Institutes of Health Research